Cart 0

ChIP-Exo-seq: Precision Beyond Traditional ChIP Assays

 

ChIP-seq (Chromatin Immunoprecipitation Sequencing),  is a technique used to analyze protein-DNA interactions.

ChIP-Exo-Seq is ideal for researchers investigating high-resolution protein-DNA interactions, epigenetic mechanisms, or transcriptional regulation in various systems, providing unparalleled insight compared to traditional ChIP assays.

Our primary antibodies validated for ChIP-Exo-Seq deliver base-pair resolution, a substantial improvement over traditional ChIP or ChIP-Seq methods. This ensures sharper, more accurate peak detection, marking exact protein-DNA binding sites.

Applications:
Commonly used to study transcription factor binding, histone modifications, and other epigenetic marks.

Benefits and Challenges:
Provides genome-wide insights into protein-DNA interactions but requires careful controls to minimize nonspecific background signals.

 

 

Unmatched Precision 

Image: Example of ChIP-Exo-Seq composite graph for Anti-ELF1 (HPA001755, Lot R00715) tested in K562 cells. Strand-specific reads (blue: forward, red: reverse) and IgG controls (black: forward, grey: reverse) are plotted against the distance from a composite set of reference binding sites. The antibody exhibits robust target enrichment compared to a non-specific IgG control and precisely reveals its structural organization around the binding site. Data generated by Prof. B. F. Pugh´s Lab at Cornell University.

 

What are the advantages of ChIP-Exo-Seq over traditional ChIP?

Higher Resolution: ChIP-exo achieves near single-base resolution of protein-DNA interactions, whereas ChIP-seq typically identifies broader regions.

Reduced Noise: Exonuclease trimming eliminates background DNA that isn’t directly protected by the protein, reducing false positives.

Precise Binding Site Localization: the sharp peaks from ChIP-exo provide more accurate mapping of transcription factor binding sites or other protein-DNA interactions.

Greater reliability, especially for “difficult” targets.

 

ChIP-Exo-Seq FAQs

 

  • What is ChIP-exo seq, and how does it differ from ChIP-seq?

    ChIP-exo seq is a refinement of ChIP-seq that uses exonuclease digestion to improve the resolution of protein-DNA interaction mapping. The exonuclease trims DNA in a 5' to 3' direction, stopping at the protein-DNA crosslink. This results in single-base resolution of binding sites, compared to the broader peaks typical of ChIP-seq. It reduces background noise and provides more precise localization of binding sites.

  • What are the key advantages of ChIP-exo seq over traditional ChIP-seq?

     

    • Single-base resolution: ChIP-exo seq provides near-base-pair precision for mapping binding sites.
    • Reduced noise: Exonuclease digestion eliminates nonspecific DNA, leading to cleaner data.
    • More accurate peak calling: Peaks are sharper and better defined compared to ChIP-seq.
    • Higher reproducibility: The improved precision leads to better reproducibility across experiments.
  • What types of applications can benefit from ChIP-exo seq?

    ChIP-exo seq is particularly useful for:

    • Identifying transcription factor binding sites with high precision.
    • Mapping histone modifications or other epigenetic markers at single-base resolution.
    • Understanding cis-regulatory elements in gene regulation.
    • Enhancing functional studies in comparative genomics or between different cell states.
  • How does the data analysis for ChIP-exo seq differ from ChIP-seq?

    In ChIP-exo seq, the data consists of sharp peaks marking the exonuclease stop points, requiring specialized analysis tools.

    The analysis pipeline involves:

    Mapping sequencing reads to the reference genome.
    Calling precise peaks using algorithms that account for single-base resolution.
    Comparing sharp peaks to motifs or regulatory elements for functional interpretation. Unlike ChIP-seq, the narrower peak width makes false positives less likely.

 

Protocol Overview:

The method combines chromatin immunoprecipitation (ChIP) with next-generation sequencing to identify binding sites of DNA-associated proteins across the genome.

Steps in the Protocol:

  • Crosslink and shear DNA 
    Proteins of interest are crosslinked to DNA to preserve protein-DNA interactions.
    The DNA is fragmented into smaller pieces using shearing methods (e.g., sonication).

  • Chromatin immunoprecipitation (ChIP)
    Specific antibodies are used to bind the protein of interest, isolating the DNA-protein complex.
    Immunoprecipitation is performed to pull down these complexes.
  • Adaptor ligation
    A first adaptor is ligated to the ends of the sheared DNA fragments.
    The ends are filled in to create blunt ends for downstream steps.
  • Exonuclease digestion (5' to 3')
    An exonuclease enzyme digests the DNA in a 5' to 3' direction.
    Digestion stops precisely at the point where the protein is crosslinked to DNA, leaving single-stranded DNA ends.
  • Reverse crosslinking and adaptor addition
    The protein-DNA crosslinks are reversed, freeing the DNA.
    The DNA is extended using primer extension, and a second adaptor is ligated to the opposite end.
  • High-throughput sequencing analysis
    The processed DNA is subjected to high-throughput sequencing to map the protein-DNA binding sites.
    The resulting sequencing data identifies sharp peaks, representing precise protein-DNA interaction sites at single-base resolution.


 

Anti-OTX2 Antibody
Anti-OTX2 Antibody

Anti-OTX2 Antibody

HPA000633
In Stock (10+)
438,0 EUR
Anti-YY1 Antibody
Anti-YY1 Antibody

Anti-YY1 Antibody

HPA001119
In Stock (10+)
438,0 EUR
Anti-SP1 Antibody
Anti-SP1 Antibody

Anti-SP1 Antibody

HPA001853
In Stock (10+)
372,0 EUR
Anti-THAP7 Antibody
Anti-THAP7 Antibody

Anti-THAP7 Antibody

HPA003083
In Stock (10+)
464,0 EUR
Anti-OLIG2 Antibody
Anti-OLIG2 Antibody

Anti-OLIG2 Antibody

HPA003254
In Stock (10+)
438,0 EUR
Anti-ZEB2 Antibody
Anti-ZEB2 Antibody

Anti-ZEB2 Antibody

HPA003456
In Stock (10+)
438,0 EUR
Anti-ZFX Antibody
Anti-ZFX Antibody

Anti-ZFX Antibody

HPA003877
In Stock (10+)
464,0 EUR
Anti-CTCF Antibody
Anti-CTCF Antibody

Anti-CTCF Antibody

HPA004122
In Stock (10+)
438,0 EUR
Anti-ZBTB17 Antibody
Anti-ZBTB17 Antibody

Anti-ZBTB17 Antibody

HPA005789
In Stock (10+)
464,0 EUR
Anti-ZNF445 Antibody
Anti-ZNF445 Antibody

Anti-ZNF445 Antibody

HPA006678
In Stock (10+)
464,0 EUR
Anti-MEF2D Antibody
Anti-MEF2D Antibody

Anti-MEF2D Antibody

HPA007114
In Stock (10+)
438,0 EUR
Anti-SKIL Antibody
Anti-SKIL Antibody

Anti-SKIL Antibody

HPA008472
In Stock (10+)
438,0 EUR
Anti-POGZ Antibody
Anti-POGZ Antibody

Anti-POGZ Antibody

HPA008781
In Stock (10+)
464,0 EUR
Anti-DACH1 Antibody
Anti-DACH1 Antibody

Anti-DACH1 Antibody

HPA012672
In Stock (10+)
438,0 EUR
Anti-FOXK1 Antibody
Anti-FOXK1 Antibody

Anti-FOXK1 Antibody

HPA018864
In Stock (10+)
464,0 EUR
Anti-TBL1XR1 Antibody
Anti-TBL1XR1 Antibody

Anti-TBL1XR1 Antibody

HPA019182
In Stock (10+)
464,0 EUR
Anti-ZFAT Antibody
Anti-ZFAT Antibody

Anti-ZFAT Antibody

HPA020989
In Stock (10+)
464,0 EUR
Anti-MLXIP Antibody
Anti-MLXIP Antibody

Anti-MLXIP Antibody

HPA023084
In Stock (10+)
464,0 EUR
Anti-CREB3L1 Antibody
Anti-CREB3L1 Antibody

Anti-CREB3L1 Antibody

HPA024069
In Stock (10+)
464,0 EUR
Anti-GATAD2A Antibody
Anti-GATAD2A Antibody

Anti-GATAD2A Antibody

HPA024373
In Stock (10+)
464,0 EUR
Anti-PRDM10 Antibody
Anti-PRDM10 Antibody

Anti-PRDM10 Antibody

HPA026997
In Stock (10+)
464,0 EUR
Anti-ZEB1 Antibody
Anti-ZEB1 Antibody

Anti-ZEB1 Antibody

HPA027524
In Stock (10+)
438,0 EUR
Anti-MED8 Antibody
Anti-MED8 Antibody

Anti-MED8 Antibody

HPA028438
In Stock (10+)
464,0 EUR
Anti-SRCAP Antibody
Anti-SRCAP Antibody

Anti-SRCAP Antibody

HPA028929
In Stock (10+)
464,0 EUR